Oct 21 (Reuters) - Oasmia Pharmaceutical AB OASM.ST :
* OASMIA ANNOUNCES GLOBAL SETTLEMENT OF ALL DISPUTES WITH
MGC
CAPITAL, FORMER BOARD MEMBERS OF OASMIA AND MEMBERS OF FORMER
MANAGEMENT
* SETTLEMENT WILL RESULT IN A NEGATIVE CASHFLOW EFFECT OF
MSEK
24.5 BUT WITH A POSITIVE EARNINGS EFFECT OF MSEK 32.5.
* EFFECTS ON EARNINGS AND CASH FLOW ARE OF A NON-REOCURRING
NATURE
AND WILL IMPACT INTERIM REPORT FOR Q4 OF 2021
Source text for Eikon: ID:nMFN64G04G
Further company coverage: OASM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))